Welcome To Biosuccess

Biosuccess Biotech Co. Ltd., is a privately held company formed in 2005 to pursue the development of PD-616 for the treatment of AML and HIV/AIDS. The concept of using PD-616 to treat these diseases stemmed from the work of Prof. Zhang Tao Han who was aware of the characteristics of PD-616 from literature reports and his own knowledge and experience in working with this agent for many years.

This led to clinical studies in China in acute myelogenous leukemia (AML) in patients who were refractory to standard therapy, had debilitating symptoms and had few if any remaining options for therapy. The results of this study were that some patients were put into partial remission and established the short term safety for the intravenous administration of PD-616.

Read More About Us

Latest News


Read More News